DFQTX
Price
$49.28
Change
+$0.46 (+0.94%)
Updated
Jun 18 closing price
Net Assets
38.89B
VSMPX
Price
$337.97
Change
+$3.81 (+1.14%)
Updated
Jun 18 closing price
Net Assets
2.31T
Interact to see
Advertisement

DFQTX vs VSMPX

DFQTX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
DFQTX vs. VSMPX commentary
Jun 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFQTX is a Hold and VSMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.31T vs. DFQTX (38.9B). VSMPX pays higher dividends than DFQTX: VSMPX (1.02) vs DFQTX (0.96). DFQTX was incepted earlier than VSMPX: DFQTX (21 years) vs VSMPX (11 years). DFQTX (0.19) is less costly to investors than VSMPX (0.02). DFQTX is a more actively managed with annual turnover of: 5.00 vs. VSMPX (3.00). DFQTX has a lower initial minimum investment than VSMPX: DFQTX (0) vs VSMPX (100000000). DFQTX annual gain was more profitable for investors over the last year : 28.07 vs. VSMPX (25.93). VSMPX (71.60) and DFQTX (69.10) have equivalent 5 years return.
DFQTXVSMPXDFQTX / VSMPX
Total Expense Ratio0.180.02900%
Annual Report Gross Expense Ratio0.190.02950%
Fund Existence21 years11 years-
Gain YTD11.68510.401112%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets38.9B2.31T2%
Annual Yield % from dividends0.961.0294%
Returns for 1 year28.0725.93108%
Returns for 3 years66.5369.0296%
Returns for 5 years69.1071.6097%
Returns for 10 years209.39249.9084%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WEGRX15.270.42
+2.83%
Allspring Emerging Growth R6
TILIX79.381.09
+1.39%
Nuveen Large Cap Gr Idx R6
FSMEX44.010.58
+1.34%
Fidelity Select Medical Tech and Devcs
BOSOX18.280.22
+1.22%
Boston Trust Walden Small Cap
BMPEX26.720.21
+0.79%
Beck Mack + Oliver Partners